MYD88 and Waldenstrom macroglobulinemia: In this case report, we highlight one such success story involving the diagnostic impact of the <i>MYD88</i><sup>L265P</sup> mutation in Waldenstrom's macroglobulinemia (WM), its prognostic implications and effect on choice of therapy in the era of novel therapies.